FREE SHIPPING with every SuperJeweler.com order! Shop Now
Published On: Thu, Aug 22nd, 2019

Retrophin scraps nervous system disorder study, shares dive

Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after it failed to improve patients’ ability to conduct daily activities such as eating and walking, sending shares down 30%.


Reuters: Health News

FREE SHIPPING with every SuperJeweler.com order! Shop Now

About the Author

-

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Advertisements

Powered by WP Robot

Retrophin scraps nervous system disorder study, shares dive